← FDA Drug Approvals (Drugs@FDA)

LIDOCAINE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: AUROBINDO PHARMA LTD · Approved 2024-06-18

Drug application

FDA Application #

ANDA217117

Application type

Abbreviated New Drug Application (Generic)

Brand name

LIDOCAINE

Generic name

LIDOCAINE

Active ingredients

LIDOCAINE

Dosage form

OINTMENT

Route

TOPICAL

Marketing status

Prescription

Sponsor

AUROBINDO PHARMA LTD

Manufacturer

Aurobindo Pharma Limited

First approval

2024-06-18

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown